Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 104

    1.

    Newer antiretroviral agents and how to use them.

    Kim HH, Daar ES.

    Curr Infect Dis Rep. 2009 Jul;11(4):327-34.PMID: 19545503 [PubMed - in process]Related articles

    2.

    Newer antiretroviral agents and how to use them.

    Kim HH, Daar ES.

    Curr HIV/AIDS Rep. 2009 May;6(2):55-62. Review.PMID: 19358775 [PubMed - indexed for MEDLINE]Related articles

    3.

    Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.

    Kearney M, Maldarelli F, Shao W, Margolick JB, Daar ES, Mellors JW, Rao V, Coffin JM, Palmer S.

    J Virol. 2009 Mar;83(6):2715-27. Epub 2008 Dec 30.PMID: 19116249 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies.

    Rieg G, Lewis RJ, Miller LG, Witt MD, Guerrero M, Daar ES.

    AIDS Patient Care STDS. 2008 Dec;22(12):947-54.PMID: 19072101 [PubMed - indexed for MEDLINE]Related articles

    5.

    Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients.

    Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, Young SK, Lee B, Heckerman D, Carlson J, Reyor LL, Kleyman M, McMahon CM, Birch C, Schulze Zur Wiesch J, Ledlie T, Koehrsen M, Kodira C, Roberts AD, Lauer GM, Rosen HR, Bihl F, Cerny A, Spengler U, Liu Z, Kim AY, Xing Y, Schneidewind A, Madey MA, Fleckenstein JF, Park VM, Galagan JE, Nusbaum C, Walker BD, Lake-Bakaar GV, Daar ES, Jacobson IM, Gomperts ED, Edlin BR, Donfield SM, Chung RT, Talal AH, Marion T, Birren BW, Henn MR, Allen TM.

    Hepatology. 2008 Dec;48(6):1769-78.PMID: 19026009 [PubMed - indexed for MEDLINE]Related articles

    6.

    Emerging resistance profiles of newly approved antiretroviral drugs.

    Daar ES.

    Top HIV Med. 2008 Oct-Nov;16(4):110-6. Review.PMID: 18838744 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance.

    Liu L, May S, Richman DD, Hecht FM, Markowitz M, Daar ES, Routy JP, Margolick JB, Collier AC, Woelk CH, Little SJ, Smith DM.

    AIDS. 2008 Apr 23;22(7):835-9.PMID: 18427201 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients and factors influencing first-line treatment regimen selection.

    Huang HY, Daar ES, Sax PE, Young B, Cook P, Benson P, Cohen C, Scribner A, Hu H.

    HIV Med. 2008 May;9(5):285-93.PMID: 18400075 [PubMed - indexed for MEDLINE]Related articles

    9.

    Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.

    Lagnese M, Daar ES.

    Expert Opin Pharmacother. 2008 Apr;9(5):687-700. Review.PMID: 18345948 [PubMed - indexed for MEDLINE]Related articles

    10.

    Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with men.

    Gorbach PM, Drumright LN, Javanbakht M, Pond SL, Woelk CH, Daar ES, Little SJ.

    J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):639-43.PMID: 18285715 [PubMed - indexed for MEDLINE]Related articles

    11.

    Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination.

    Balamurugan A, Lewis MJ, Kitchen CM, Robertson MN, Shiver JW, Daar ES, Pitt J, Ali A, Ng HL, Currier JS, Yang OO.

    J Virol. 2008 Mar;82(6):2784-91. Epub 2008 Jan 16.PMID: 18199650 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Clinical presentation and diagnosis of primary HIV-1 infection.

    Daar ES, Pilcher CD, Hecht FM.

    Curr Opin HIV AIDS. 2008 Jan;3(1):10-15.PMID: 19372938 [PubMed - as supplied by publisher]Related articles

    13.

    Platelet count is associated with plasma HIV type 1 RNA and disease progression.

    Rieg G, Yeaman M, Lail AE, Donfield SM, Gomperts ED, Daar ES; Hemophilia Growth and Development Study (HGDS).

    AIDS Res Hum Retroviruses. 2007 Oct;23(10):1257-61.PMID: 17961113 [PubMed - indexed for MEDLINE]Related articles

    14.

    A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients.

    Best BM, Goicoechea M, Witt MD, Miller L, Daar ES, Diamond C, Tilles JG, Kemper CA, Larsen R, Holland DT, Sun S, Jain S, Wagner G, Capparelli EV, McCutchan JA, Haubrich RH; California Collaborative Treatment Group 578 Study Team.

    J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):433-42.PMID: 17786128 [PubMed - indexed for MEDLINE]Related articles

    15.

    Incorporating novel virologic tests into clinical practice.

    Daar ES.

    Top HIV Med. 2007 Aug-Sep;15(4):126-9. Review.PMID: 17720997 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Baseline HIV type 1 coreceptor tropism predicts disease progression.

    Daar ES, Kesler KL, Petropoulos CJ, Huang W, Bates M, Lail AE, Coakley EP, Gomperts ED, Donfield SM; Hemophilia Growth and Development Study.

    Clin Infect Dis. 2007 Sep 1;45(5):643-9. Epub 2007 Jul 20. Erratum in: Clin Infect Dis. 2007 Dec 15;45(12):1656. PMID: 17683002 [PubMed - indexed for MEDLINE]Related articles

    17.

    New approaches and resolve may define the future of the global HIV pandemic.

    Daar ES.

    Res Initiat Treat Action. 2007 Winter;12(2):8-10. No abstract available. PMID: 17486706 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hepatitis C virus and death risk in hemodialysis patients.

    Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S.

    J Am Soc Nephrol. 2007 May;18(5):1584-93. Epub 2007 Apr 11.PMID: 17429053 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Measuring below the bar: what is it telling us?

    Daar ES.

    AIDS. 2006 Nov 28;20(18):2385-7. No abstract available. PMID: 17117026 [PubMed - indexed for MEDLINE]Related articles

    20.

    Unprotected anal intercourse and substance use before and after HIV diagnosis among recently HIV-infected men who have sex with men.

    Drumright LN, Strathdee SA, Little SJ, Araneta MR, Slymen DJ, Malcarne VL, Daar ES, Gorbach PM.

    Sex Transm Dis. 2007 Jun;34(6):401-7.PMID: 17091117 [PubMed - indexed for MEDLINE]Related articles

    21.

    Novel Antiretroviral Agents in HIV Therapy.

    Reed C, Daar ES.

    Curr Infect Dis Rep. 2006 Nov;8(6):489-96.PMID: 17064643 [PubMed - in process]Related articles

    22.

    Hepatitis C virus infection and neurocognitive function.

    Soogoor M, Lynn HS, Donfield SM, Gomperts E, Bell TS, Daar ES; Hemophilia Growth and Development Study.

    Neurology. 2006 Oct 24;67(8):1482-5.PMID: 17060580 [PubMed - indexed for MEDLINE]Related articles

    23.

    Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity.

    Barbour JD, Hecht FM, Little SJ, Markowitz M, Daar ES, Kelleher AD, Routy JP, Campbell TB, Rosenberg ES, Segal MR, Weidler J, Grant RM.

    AIDS. 2006 Oct 24;20(16):2123-5.PMID: 17053362 [PubMed - indexed for MEDLINE]Related articles

    24.

    Characteristics of recently HIV-infected men who use the Internet to find male sex partners and sexual practices with those partners.

    Smith DM, Drumright LN, Frost SD, Cheng WS, Espitia S, Daar ES, Little SJ, Gorbach PM.

    J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):582-7.PMID: 17019370 [PubMed - indexed for MEDLINE]Related articles

    25.

    Hepatitis C infection in dialysis patients: a link to poor clinical outcome?

    Kalantar-Zadeh K, Daar ES, Eysselein VE, Miller LG.

    Int Urol Nephrol. 2007;39(1):247-59. Epub 2006 Sep 29. Review.PMID: 17009087 [PubMed - indexed for MEDLINE]Related articles

    26.

    Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection.

    Drumright LN, Little SJ, Strathdee SA, Slymen DJ, Araneta MR, Malcarne VL, Daar ES, Gorbach PM.

    J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):344-50.PMID: 16980913 [PubMed - indexed for MEDLINE]Related articles

    27.

    Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.

    Smith DM, Strain MC, Frost SD, Pillai SK, Wong JK, Wrin T, Liu Y, Petropolous CJ, Daar ES, Little SJ, Richman DD.

    Virology. 2006 Nov 10;355(1):1-5. Epub 2006 Sep 7.PMID: 16962152 [PubMed - indexed for MEDLINE]Related articles

    28.

    Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578).

    Wagner GJ, Kanouse DE, Golinelli D, Miller LG, Daar ES, Witt MD, Diamond C, Tilles JG, Kemper CA, Larsen R, Goicoechea M, Haubrich RH.

    AIDS. 2006 Jun 12;20(9):1295-302.PMID: 16816559 [PubMed - indexed for MEDLINE]Related articles

    29.

    Transmission behaviors of recently HIV-infected men who have sex with men.

    Gorbach PM, Drumright LN, Daar ES, Little SJ.

    J Acquir Immune Defic Syndr. 2006 May;42(1):80-5.PMID: 16763494 [PubMed - indexed for MEDLINE]Related articles

    30.

    Human immunodeficiency virus and fertility care: embarking on a path of knowledge and access.

    Daar ES, Daar JF.

    Fertil Steril. 2006 Feb;85(2):298-300; discussion 301. Review.PMID: 16595202 [PubMed - indexed for MEDLINE]Related articles

    31.

    Molecular analysis of HIV strains from a cluster of worker infections in the adult film industry, Los Angeles 2004.

    Brooks JT, Robbins KE, Youngpairoj AS, Rotblatt H, Kerndt PR, Taylor MM, Daar ES, Kalish ML.

    AIDS. 2006 Apr 4;20(6):923-8.PMID: 16549978 [PubMed - indexed for MEDLINE]Related articles

    32.

    Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression.

    Daar ES, Lynn HS, Donfield SM, Lail A, O'Brien SJ, Huang W, Winkler CA; Hemophilia Growth and Development Study.

    J Infect Dis. 2005 Nov 1;192(9):1597-605. Epub 2005 Sep 30.PMID: 16206074 [PubMed - indexed for MEDLINE]Related articles

    33.

    Diagnostic discordance for hepatitis C virus infection in hemodialysis patients.

    Kalantar-Zadeh K, Miller LG, Daar ES.

    Am J Kidney Dis. 2005 Aug;46(2):290-300.PMID: 16112048 [PubMed - indexed for MEDLINE]Related articles

    34.

    Primary human immunodeficiency virus type 1 infection.

    Soogoor M, Daar ES.

    Curr HIV/AIDS Rep. 2005 Jun;2(2):55-60. Review.PMID: 16091249 [PubMed - indexed for MEDLINE]Related articles

    35.

    HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load.

    Frahm N, Adams S, Kiepiela P, Linde CH, Hewitt HS, Lichterfeld M, Sango K, Brown NV, Pae E, Wurcel AG, Altfeld M, Feeney ME, Allen TM, Roach T, St John MA, Daar ES, Rosenberg E, Korber B, Marincola F, Walker BD, Goulder PJ, Brander C.

    J Virol. 2005 Aug;79(16):10218-25.PMID: 16051815 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Longitudinal analysis of CD8 T-cell responses to HIV and hepatitis C virus in a cohort of co-infected haemophiliacs.

    Harcourt GC, Donfield S, Gomperts E, Daar ES, Goulder P Jr, Phillips RE, Klenerman P; Hemophilia Growth and Development Study (HGDS).

    AIDS. 2005 Jul 22;19(11):1135-43.PMID: 15990566 [PubMed - indexed for MEDLINE]Related articles

    37.

    Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance.

    Daar ES, Richman DD.

    AIDS Res Hum Retroviruses. 2005 May;21(5):343-57. Review.PMID: 15929696 [PubMed - indexed for MEDLINE]Related articles

    38.

    HIV-1 pol replication capacity predicts disease progression.

    Daar ES, Kesler KL, Wrin T, Petropoulo CJ, Bates M, Lail A, Hellmann NS, Gomperts E, Donfield S; Hemophilia Growth and Development Study.

    AIDS. 2005 Jun 10;19(9):871-7.PMID: 15905667 [PubMed - indexed for MEDLINE]Related articles

    39.

    Strategies for initiating combination antiretroviral therapy.

    Tapper ML, Daar ES, Piliero PJ, Smith K, Steinhart C.

    AIDS Patient Care STDS. 2005 Apr;19(4):224-38. Review.PMID: 15857194 [PubMed - indexed for MEDLINE]Related articles

    40.

    Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

    Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK.

    J Infect Dis. 2005 May 1;191(9):1410-8. Epub 2005 Mar 29.PMID: 15809898 [PubMed - indexed for MEDLINE]Related articles

    41.

    Primary HIV-1 Infection: Diagnosis, Pathogenesis, and Treatment.

    Soogoor M, Daar ES.

    Curr Infect Dis Rep. 2005 Mar;7(2):147-153.PMID: 15727743 [PubMed - as supplied by publisher]Related articles

    42.

    Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.

    Yang OO, Daar ES, Jamieson BD, Balamurugan A, Smith DM, Pitt JA, Petropoulos CJ, Richman DD, Little SJ, Brown AJ.

    J Virol. 2005 Jan;79(2):860-8.PMID: 15613314 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease.

    Yoo TW, Donfield S, Lail A, Lynn HS, Daar ES; Hemophilia Growth and Development Study.

    J Infect Dis. 2005 Jan 1;191(1):4-10. Epub 2004 Dec 2.PMID: 15592996 [PubMed - indexed for MEDLINE]Related articles

    44.

    What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 2.

    Ruane PJ, Daar ES.

    AIDS Read. 2004 Sep;14(9):487-98. Review.PMID: 15457602 [PubMed - indexed for MEDLINE]Related articles

    45.

    Incidence of HIV superinfection following primary infection.

    Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES, Richman DD, Little SJ.

    JAMA. 2004 Sep 8;292(10):1177-8. No abstract available. PMID: 15353529 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 1.

    Ruane PJ, Daar ES.

    AIDS Read. 2004 Aug;14(8):421-6, 431-2, 434. Review.PMID: 15338522 [PubMed - indexed for MEDLINE]Related articles

    47.

    Antiretroviral rounds. Putting resistance to work.

    Daar ES, Elion R.

    AIDS Clin Care. 2004 Jul;16(7):56, 60. No abstract available. PMID: 15300926 [PubMed - indexed for MEDLINE]Related articles

    48.

    Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes.

    Sagar M, Kirkegaard E, Long EM, Celum C, Buchbinder S, Daar ES, Overbaugh J.

    J Virol. 2004 Jul;78(13):7279-83.PMID: 15194805 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy.

    Moyle GJ, Daar ES, Gertner JM, Kotler DP, Melchior JC, O'brien F, Svanberg E; Serono 9037 Study Team.

    J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):367-75.PMID: 15097153 [PubMed - indexed for MEDLINE]Related articles

    50.

    Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection.

    Leigh Brown AJ, Frost SD, Good B, Daar ES, Simon V, Markowitz M, Collier AC, Connick E, Conway B, Margolick JB, Routy JP, Corbeil J, Hellmann NS, Richman DD, Little SJ.

    J Virol. 2004 Mar;78(5):2242-6.PMID: 14963120 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...